SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The March 2025 quarter revenue stood at Rs. 1681.83 millions, up 18.03% as compared to Rs. 1424.93 millions during the corresponding quarter last year.Net Profit of the company move down -37.76% to Rs. 115.74  millions from Rs. 185.97 millions  in the same quarter last year.Operating profit for the quarter ended March 2025 decreased to 198.39 millions as compared to 254.02 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 1681.83 1424.93 18.03 6232.30 5805.50 7.35 6232.30 5805.50 7.35
Other Income -68.80 70.19 -198.02 224.77 344.22 -34.70 224.77 344.22 -34.70
PBIDT 198.39 254.02 -21.90 1239.71 1343.30 -7.71 1239.71 1343.30 -7.71
Interest 3.67 4.99 -26.45 18.83 14.63 28.71 18.83 14.63 28.71
PBDT 194.72 249.03 -21.81 1220.88 1328.67 -8.11 1220.88 1328.67 -8.11
Depreciation 32.26 26.86 20.10 128.99 106.25 21.40 128.99 106.25 21.40
PBT 162.46 222.17 -26.88 1091.89 1222.42 -10.68 1091.89 1222.42 -10.68
TAX 46.72 36.20 29.06 268.42 289.38 -7.24 268.42 289.38 -7.24
Deferred Tax -19.79 -4.93 301.42 15.15 34.95 -56.65 15.15 34.95 -56.65
PAT 115.74 185.97 -37.76 823.47 933.04 -11.74 823.47 933.04 -11.74
Equity 200.30 200.30 0.00 200.30 200.30 0.00 200.30 200.30 0.00
PBIDTM(%) 11.80 17.83 -33.83 19.89 23.14 -14.03 19.89 23.14 -14.03

Lincoln Pharma Share Price

645.40 -28.20 (-4.19%)
30-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.20
Dr. Reddys Lab 1322.95
Cipla 1309.90
Zydus Lifesciences 891.65
Lupin 2303.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×